MicroRNA let-7g inhibits angiotensin II-induced endothelial senescence via the LOX-1-independent mechanism

Hsu,Po‑Yuan; Lin,Wen‑Yi; Lin,Ruey‑Tay; Juo,Suh‑Hang  H.

doi:10.3892/ijmm.2018.3416

MicroRNA let-7g inhibits angiotensin II-induced endothelial senescence via the LOX-1-independent mechanism

Authors:
- Po‑Yuan Hsu
- Wen‑Yi Lin
- Ruey‑Tay Lin
- Suh‑Hang H. Juo
View Affiliations

Affiliations: Department of Medical Research, China Medical University Hospital, Taichung 40402, Taiwan R.O.C., Department of Occupational Medicine, Kaohsiung Municipal Hsiaokang Hospital, Kaohsiung 80708, Taiwan R.O.C., Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan R.O.C.
Published online on: January 23, 2018 https://doi.org/10.3892/ijmm.2018.3416
Pages: 2243-2251

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Endothelial senescence leads to cell dysfunction, which in turn eventually results in cardiovascular disease. Identifying factors that regulate endothelial senescence may provide insight into the pathogenesis of aging. Insulin-like growth factor (IGF) signaling has a significant role in the physiology of endothelial cells (ECs). Overactivation of IGF signaling has been implicated in promoting the aging process. Lectin‑like oxidized low‑density lipoprotein (oxLDL) receptor‑1 (LOX‑1) is a scavenger receptor that mediates the internalization of oxLDL into cells. Previous studies by our group have indicated that microRNA let‑7g exerts an anti‑aging effect on ECs and also suppresses LOX-1 expression. Since LOX‑1 also induces the aging process, the present study we explored whether let‑7g still exerts an anti‑aging effect on ECs when LOX‑1 is suppressed. Angiotensin II (Ang II) was used to induce senescence in ECs. It was revealed that Ang II significantly increased the expression of aging markers, including β‑galactosidase, LOX‑1, IGF1 and its receptor IGF1R. On the contrary, Ang II decreased the expression of the anti‑aging gene sirtuin 1 (SIRT1). When LOX‑1 was knocked down by small interfering RNA, let‑7g still dose‑dependently decreased the expression of β‑galactosidase (β‑gal), LOX‑1, IGF1 and IGF1R, and SIRT1 was still upregulated. Using senescence‑associated β‑gal staining, it was confirmed that let‑7g exerts a LOX‑1‑independent anti‑aging effect on ECs. In conclusion, the present study demonstrated that let‑7g has an anti‑aging effect regardless of the presence or absence of LOX-1.

View Figures

View References

1	Campisi J: Aging, cellular senescence, and cancer. Annu Rev Physiol. 75:685–705. 2013. View Article : Google Scholar
2	Félétou M and Vanhoutte PM: Endothelial dysfunction: A multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol. 291:H985–H1002. 2006. View Article : Google Scholar : PubMed/NCBI
3	Xu S, Ogura S, Chen J, Little PJ, Moss J and Liu P: LOX-1 in atherosclerosis: Biological functions and pharmacological modifiers. Cell Mol Life Sci. 70:2859–2872. 2013. View Article : Google Scholar
4	Wang X, Khaidakov M, Ding Z, Dai Y, Mercanti F and Mehta JL: LOX-1 in the maintenance of cytoskeleton and proliferation in senescent cardiac fibroblasts. J Mol Cell Cardiol. 60:184–190. 2013. View Article : Google Scholar : PubMed/NCBI
5	Mehta PK and Griendling KK: Angiotensin II cell signaling: Physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol. 292:C82–C97. 2007. View Article : Google Scholar
6	Kambayashi Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T and Inagami T: Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem. 268:24543–24546. 1993.PubMed/NCBI
7	Sasaki K, Yamano Y, Bardhan S, Iwai N, Murray JJ, Hasegawa M, Matsuda Y and Inagami T: Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature. 351:230–233. 1991. View Article : Google Scholar : PubMed/NCBI
8	Min LJ, Mogi M, Iwai M and Horiuchi M: Signaling mechanisms of angiotensin II in regulating vascular senescence. Ageing Res Rev. 8:113–121. 2009. View Article : Google Scholar : PubMed/NCBI
9	Kunieda T, Minamino T, Nishi J, Tateno K, Oyama T, Katsuno T, Miyauchi H, Orimo M, Okada S, Takamura M, et al: Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway. Circulation. 114:953–960. 2006. View Article : Google Scholar : PubMed/NCBI
10	Li DY, Zhang YC, Philips MI, Sawamura T and Mehta JL: Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation. Circ Res. 84:1043–1049. 1999. View Article : Google Scholar : PubMed/NCBI
11	Feige JN and Auwerx J: Transcriptional targets of sirtuins in the coordination of mammalian physiology. Curr Opin Cell Biol. 20:303–309. 2008. View Article : Google Scholar : PubMed/NCBI
12	Liao YC, Wang YS, Guo YC, Lin WL, Chang MH and Juo SH: Let-7g improves multiple endothelial functions through targeting transforming growth factor-beta and SIRT-1 signaling. J Am Coll Cardiol. 63:1685–1694. 2014. View Article : Google Scholar
13	Gorenne I, Kumar S, Gray K, Figg N, Yu H, Mercer J and Bennett M: Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis. Circulation. 127:386–396. 2013. View Article : Google Scholar
14	Stein S, Lohmann C, Schäfer N, Hofmann J, Rohrer L, Besler C, Rothgiesser KM, Becher B, Hottiger MO, Borén J, et al: SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis. Eur Heart J. 31:2301–2309. 2010. View Article : Google Scholar : PubMed/NCBI
15	Zhang QJ, Wang Z, Chen HZ, Zhou S, Zheng W, Liu G, Wei YS, Cai H, Liu DP and Liang CC: Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apoli-poprotein E-deficient mice. Cardiovasc Res. 80:191–199. 2008. View Article : Google Scholar : PubMed/NCBI
16	Kenyon C: A conserved regulatory system for aging. Cell. 105:165–168. 2001. View Article : Google Scholar : PubMed/NCBI
17	Longo VD and Finch CE: Evolutionary medicine: From dwarf model systems to healthy centenarians? Science. 299:1342–1346. 2003. View Article : Google Scholar : PubMed/NCBI
18	Lai CH, Ho TJ, Kuo WW, Day CH, Pai PY, Chung LC, Liao PH, Lin FH, Wu ET and Huang CY: Exercise training enhanced SIRT1 longevity signaling replaces the IGF1 survival pathway to attenuate aging-induced rat heart apoptosis. Age (Dordr). 36:97062014. View Article : Google Scholar
19	Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, et al: Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science. 303:2011–2015. 2004. View Article : Google Scholar : PubMed/NCBI
20	Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, Gorospe M, de Cabo R and Sinclair DA: Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science. 305:390–392. 2004. View Article : Google Scholar : PubMed/NCBI
21	Tissenbaum HA and Guarente L: Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature. 410:227–230. 2001. View Article : Google Scholar : PubMed/NCBI
22	Bushati N and Cohen SM: microRNA functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar : PubMed/NCBI
23	Bao MH, Feng X, Zhang YW, Lou XY, Cheng Y and Zhou HH: Let-7 in cardiovascular diseases, heart development and cardiovascular differentiation from stem cells. Int J Mol Sci. 14:23086–23102. 2013. View Article : Google Scholar : PubMed/NCBI
24	Chiu SC, Chung HY, Cho DY, Chan TM, Liu MC, Huang HM, Li TY, Lin JY, Chou PC, Fu RH, et al: Therapeutic potential of microRNA let-7: Tumor suppression or impeding normal stemness. Cell Transplant. 23:459–469. 2014. View Article : Google Scholar : PubMed/NCBI
25	Chen KC, Hsieh IC, His E, Wang YS, Dai CY, Chou WW and Juo SH: Negative feedback regulation between microRNA let-7g and the oxLDL receptor LOX-1. J Cell Sci. 124:4115–4124. 2011. View Article : Google Scholar : PubMed/NCBI
26	Hsu PY, His E, Wang TM, Lin RT, Liao YC and Juo SH: MicroRNA let-7g possesses a therapeutic potential for peripheral artery disease. J Cell Mol Med. 21:519–529. 2017. View Article : Google Scholar
27	Yang LL, Li DY, Zhang YB, Zhu MY, Chen D and Xu TD: Salvianolic acid A inhibits angiotensin II-induced proliferation of human umbilical vein endothelial cells by attenuating the production of ROS. Acta Pharmacol Sin. 33:41–48. 2012. View Article : Google Scholar
28	Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
29	Choo KB, Soon YL, Nguyen PN, Hiew MS and Huang CJ: MicroRNA-5p and -3p co-expression and cross-targeting in colon cancer cells. J Biomed Sci. 21:952014. View Article : Google Scholar : PubMed/NCBI
30	Zhou J, Yao W, Liu K, Wen Q, Wu W, Liu H and Li Q: MicroRNA let-7g regulates mouse granulosa cell autophagy by targeting insulin-like growth factor 1 receptor. Int J Biochem Cell Biol. 78:130–140. 2016. View Article : Google Scholar : PubMed/NCBI
31	Shan H, Bai X and Chen X: Angiotensin II induces endothelial cell senescence via the activation of mitogen-activated protein kinases. Cell Biochem Funct. 26:459–466. 2008. View Article : Google Scholar : PubMed/NCBI
32	Zhang Y, Huang XR, Wei LH, Chung AC, Yu CM and Lan HY: miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signaling. Mol Ther. 22:974–985. 2014. View Article : Google Scholar : PubMed/NCBI
33	Hu Z, Klein JD, Mitch WE, Zhang L, Martinez I and Wang XH: MicroRNA-29 induces cellular senescence in aging muscle through multiple signaling pathways. Aging (Albany NY). 6:160–175. 2014. View Article : Google Scholar :
34	Xu Z, Zhang L, Fei X, Yi X, Li W and Wang Q: The miR-29b-Sirt1 axis regulates self-renewal of mouse embryonic stem cells in response to reactive oxygen species. Cell Signal. 26:1500–1505. 2014. View Article : Google Scholar : PubMed/NCBI
35	Pirillo A, Norata GD and Catapano AL: LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm. 2013:1527862013. View Article : Google Scholar : PubMed/NCBI
36	Morawietz H, Rueckschloss U, Niemann B, Duerrschmidt N, Galle J, Hakim K, Zerkowski HR, Sawamura T and Holtz J: Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein. Circulation. 100:899–902. 1999. View Article : Google Scholar : PubMed/NCBI
37	Rodriguez-Perez AI, Borrajo A, Diaz-Ruiz C, Garrido-Gil P and Labandeira-Garcia JL: Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: Role in neuroinflammation and aging. Oncotarget. 7:30049–30067. 2016. View Article : Google Scholar : PubMed/NCBI
38	Suh Y, Atzmon G, Cho MO, Hwang D, Liu B, Leahy DJ, Barzilai N and Cohen P: Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc Natl Acad Sci USA. 105:3438–3442. 2008. View Article : Google Scholar : PubMed/NCBI
39	Dubinsky AN, Dastidar SG, Hsu CL, Zahra R, Djakovic SN, Duarte S, Esau CC, Spencer B, Ashe TD, Fischer KM, et al: Let-7 coordinately suppresses components of the amino acid sensing pathway to repress mTORC1 and induce autophagy. Cell Metab. 20:626–638. 2014. View Article : Google Scholar : PubMed/NCBI
40	Zhu H, Shyh-Chang N, Segrè AV, Shinoda G, Shah SP, Einhorn WS, Takeuchi A, Engreitz JM, Hagan JP, Kharas MG, et al: The Lin28/let-7 axis regulates glucose metabolism. Cell. 147:81–94. 2011. View Article : Google Scholar : PubMed/NCBI